Novogen
Novogen develops a technology that improves the ability of drugs to treat cancer cells.
Launch date
Employees
Market cap
-
Enterprise valuation
$18—27m (Dealroom.co estimates Jul 2013.)
Sydney New South Wales (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
$4.5m | Early VC | ||
| Total Funding | $4.5m | ||
Recent News about Novogen
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.